Dr. Chang teaches “Decision Analysis for Clinical Investigation and Economic Evaluation” in the Master of Population Health Sciences (MPHS) degree program.

Publications and Abstracts from Students taking the Course:

  1. Leung M, Pollack LM, Colditz GA, Chang S-H. Life years lost and lifetime healthcare expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997-2000. Diabetes Care, 2015;38:1-9. PMID: 25552420; PMCID: PMC4338508. [Altmetric]
  2. Samson P, Patel A, Robinson CG, Morgensztern D, Chang S-H, Colditz GA, Waqar S, Crabtree TD, Krupnick AS, Kreisel D, Patterson GA, Meyers BF, Puri V. The role of surgical resection in stage IIIA non-small cell lung cancer: a decision and cost-effectiveness analysis. Ann Thorac Surg. 2015;100(6):2026-2032. PMID: 26319488; PMCID: PMC4847712. [Altmetric]
  3. Hudson JL, Chang S-H, Olsen MA, Meyers BF, Morgensztern D, Puri V. “The role of adjuvant chemotherapy in stage IB non-small cell lung cancer: a decision and cost-utility analysis”, Washington University School of Medicine Samuel Wells Day Resident Research Competition (winner), April 27, 2016.
  4. Semenkovich TR, Panni RZ, Hudson JL, Thomas T, Elmore LC, Chang S-H, Meyers BF, Kozower BD, Puri V. Comparative effectiveness of upfront esophagectomy vs induction chemoradiation in clinical stage T2N0 esophageal cancer: a decision analysis. The Journal of Thoracic Cardiovascular Surgery. 2018;155(5):2221-2230. PMID: 29428700; PMCID: PMC5914532. [Altmetric]
  5. Rosenbloom J, Lewkowitz A, Sondgeroth K, Hudson J, Macones G, Cahill A, Tuuli M, Chang S-H. Antenatal corticosteroid administration in late-preterm gestations: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2018 Oct 24. PMID: 30353764; PMCID: PMC6520203.
  6. McEvoy AM, Poplack S, Nickel K, Olsen MA, Ademuyiwa F, Zoberi I, Odom E, Yu J, Chang S-H, Gillanders WE. Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR+ breast cancer and negative axillary ultrasound. Breast Cancer Res Treat. 2020 Jul 10. PMID: 32651755.
  7. Chapman W, Hao J, Shah A, Rosen D, Mutch M, Hunt S, Chang S-H, Silviera M. “Doing More with Less – A Decision Analysis of Nonoperative Management in Rectal Cancer”, Washington University School of Medicine Samuel Wells Day Resident Research Competition (winner), May 9, 2018.
  8. Subramanian MP, Yang Z, Chang SH, Puri V. Regionalization for thoracic surgery: Economic implications of regionalization in the United States. J Thorac Cardiovasc Surg. 2021 May;161(5):1705-1709. doi: 10.1016/j.jtcvs.2020.10.132. Epub 2020 Nov 19. PMID: 33323196; PMCID: PMC8691896.
  9. Heiden BT, Mitchell JD, Rome E, Puri V, Meyers BF, Chang S-H, Kozower BD. Cost-effectiveness analysis of robot-assisted lobectomy for non-small cell lung cancer. The Annals of Thoracic Surgery. 2021 Aug 10;S0003-4975(21)01389-8. PubMed PMID: 34389311.[Link]
  10. Chin RI, Otegbeye E, Kang KH, Chang S-H, McHenry S, Roy A, Badiyan S, Chapman Jr WC, Glasgow SC, Henke LE, Hunt SR, Pedersen K, Samson P, Silviera ML, Tan BR, Wise PE, Mutch MG, Kim H. “Economic Evaluation of Total Neoadjuvant Therapy in Rectal Cancer: Short-Course Radiation Therapy vs. Long-Course Chemoradiation” 103rd Annual American Radium Society Meeting (Early Career Oncologist Award), September 29-30, 2021
  11. Chin R-I, Otegbeye EE, Kang KH, Chang S-H, McHenry S, Roy A, Chapman Jr WC, Henke LE, Badiyan S, Pedersen K, Tan BR, Glasgow SC, Mutch MG, Samson P, Kim H. Cost-effectiveness of total neoadjuvant therapy with short-course radiotherapy for resectable locally advanced rectal cancer. JAMA Network Open. 2022 Feb 1;5(2):e2146312. PubMed PMID: 35103791. PubMed Central PMCID: PMC8808328.
  12. Michael Daniel, Cassandra Fritz, Tsehay Abebe, Ahmad N. Bazarbashi, Shelby Sullivan, Chang S-H, Vladimir Kushnir.Cost-effectiveness Analysis of Endoscopic Sleeve Gastroplasty,Techniques and Innovations in Gastrointestinal Endoscopy,2024,ISSN 2590-0307.[Link]
  13. Raval N, Shah A, Chang S-H, Grover P. Cost-effectiveness of lower limb prosthetic devices for mobility in older adults with dysvascular amputations. Journal of the International Society of Physical and Rehabilitation Medicine 7(2):p 54-59, June 2024. | DOI: 10.1097/ph9.0000000000000031.[Link]